CATALOGO DEI PRODOTTI DELLA RICERCA

CORBO, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.945
EU - Europa 7.648
AS - Asia 5.451
SA - Sud America 796
Continente sconosciuto - Info sul continente non disponibili 360
AF - Africa 174
OC - Oceania 46
Totale 23.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.553
RU - Federazione Russa 2.830
SG - Singapore 2.068
CN - Cina 1.525
IT - Italia 1.406
GB - Regno Unito 1.331
BR - Brasile 611
HK - Hong Kong 564
VN - Vietnam 481
DE - Germania 408
IE - Irlanda 307
SE - Svezia 300
FR - Francia 297
FI - Finlandia 208
CA - Canada 193
BD - Bangladesh 156
KR - Corea 154
NL - Olanda 154
IN - India 107
JP - Giappone 69
UA - Ucraina 69
AT - Austria 67
ES - Italia 62
AR - Argentina 60
TR - Turchia 50
MX - Messico 49
ID - Indonesia 46
PL - Polonia 42
AU - Australia 40
NG - Nigeria 36
IQ - Iraq 35
BE - Belgio 31
CO - Colombia 31
ZA - Sudafrica 31
EC - Ecuador 30
JM - Giamaica 25
TG - Togo 24
CR - Costa Rica 23
UZ - Uzbekistan 22
VE - Venezuela 21
HN - Honduras 19
BJ - Benin 18
JO - Giordania 18
PK - Pakistan 18
LT - Lituania 17
MA - Marocco 17
NI - Nicaragua 17
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
CH - Svizzera 15
GT - Guatemala 15
IR - Iran 15
PH - Filippine 14
PY - Paraguay 14
MY - Malesia 13
CL - Cile 11
SV - El Salvador 11
CW - ???statistics.table.value.countryCode.CW??? 10
KE - Kenya 10
PR - Porto Rico 10
TN - Tunisia 10
AZ - Azerbaigian 9
BG - Bulgaria 9
IL - Israele 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
AL - Albania 8
NP - Nepal 8
TH - Thailandia 8
EE - Estonia 7
EG - Egitto 7
DK - Danimarca 6
GP - Guadalupe 6
GR - Grecia 6
PE - Perù 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
HU - Ungheria 5
KG - Kirghizistan 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
BB - Barbados 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
PA - Panama 4
UY - Uruguay 4
BN - Brunei Darussalam 3
DZ - Algeria 3
GD - Grenada 3
MD - Moldavia 3
OM - Oman 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 23.029
Salva come PNG Salva come JPEG
Città #
Ashburn 1.337
Southend 1.100
Singapore 1.059
Moscow 959
San Jose 869
Chandler 706
Dallas 662
Hong Kong 543
Verona 531
Council Bluffs 358
Beijing 343
Dublin 289
Jacksonville 241
New York 240
The Dalles 224
Ann Arbor 220
Woodbridge 207
Los Angeles 178
Ho Chi Minh City 135
Munich 130
Hanoi 118
Santa Clara 113
Jinan 107
Milan 103
Princeton 99
Lawrence 97
Houston 96
Wilmington 91
Redmond 83
Shenyang 69
São Paulo 69
Nanjing 67
Helsinki 65
Buffalo 62
Orem 61
Redondo Beach 59
Tokyo 58
London 53
Turku 50
Hebei 49
Columbus 48
Rome 48
Tianjin 47
Amsterdam 43
Brooklyn 41
Sindelfingen 41
Denver 40
Vienna 40
Zhengzhou 40
Haikou 38
Warsaw 38
Montreal 37
Chicago 36
Seattle 36
Abuja 35
Changsha 35
Toronto 35
Chennai 34
Dearborn 34
Frankfurt am Main 34
Ningbo 34
Phoenix 33
Hangzhou 31
Nuremberg 31
Brussels 30
San Francisco 29
Dong Ket 28
Stockholm 28
Atlanta 27
Bologna 27
Lappeenranta 27
Madrid 27
Washington 27
Guangzhou 25
Jakarta 24
Lomé 24
Manchester 24
Taiyuan 24
Boardman 23
Poplar 22
Redwood City 22
Haiphong 21
Johannesburg 20
Taizhou 20
Ankara 19
Barnet 19
Boston 19
Las Vegas 19
Mexico City 19
Nanchang 19
Naples 19
Cotonou 18
Falkenstein 18
McKinney 18
San José 18
Sydney 18
Tashkent 18
Charlotte 17
Jiaxing 17
Brescia 16
Totale 13.599
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 401
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 319
Whole-genome landscape of pancreatic neuroendocrine tumours 297
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 293
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 278
Mutational analysis of cancer candidate genes in different pancreatic cancer types 276
Genomic analyses identify molecular subtypes of pancreatic cancer 272
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 262
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 252
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 234
RON is not a prognostic marker for resectable pancreatic cancer 228
Sex differences in oncogenic mutational processes 225
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 223
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 222
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 219
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 218
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer 210
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 210
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 210
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 210
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 209
Complete neural stem cell (nsc) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism 208
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 207
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation 205
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 205
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 204
Reporting tumor molecular heterogeneity in histopathological diagnosis 204
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 204
Author Correction: The landscape of viral associations in human cancers 203
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 203
Divergent mutational processes distinguish hypoxic and normoxic tumours 202
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 202
Pancreatic cancer genomics 198
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 198
Lost in translation: returning germline genetic results in genome-scale cancer research 196
Comparative Lesions Analysis Through a Targeted Sequencing Approach 195
Molecular biology of neuroendocrine tumors 191
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 191
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 190
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 190
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 189
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 189
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 187
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 187
Fhit down-regulation is an early event in pancreatic carcinogenesis 186
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 183
Hypermutation In Pancreatic Cancer 183
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 182
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 180
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 180
Molecular Pathology of Pancreatic Cancer: from bench-to-bedside translation. 179
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance 179
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 178
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 178
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 178
Loss of FGFR4 promotes the malignant phenotype of PDAC 177
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 176
Local ablation disrupts immune evasion in pancreatic cancer 175
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 174
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 173
Exosomal miRNA signatures of pancreatic lesions 171
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 171
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 170
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 170
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 169
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 167
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 166
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 166
Molecular alterations in basal cell carcinoma subtypes 166
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 164
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 164
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 163
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 163
Muscle derangement and alteration of the nutritional machinery in NSCLC 162
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 162
Generation of Pancreatic Organoid-Derived Isografts 162
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 158
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 157
Whole genomes redefine the mutational landscape of pancreatic cancer 157
Long-term organoid culture of a small intestinal neuroendocrine tumor 156
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 155
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 155
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 155
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 155
Author Correction: Pan-cancer analysis of whole genomes 155
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 152
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer 152
Combined burden and functional impact tests for cancer driver discovery using DriverPower 151
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 149
Profiling mTOR pathway in neuroendocrine tumors. 148
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 147
Comprehensive molecular characterization of mitochondrial genomes in human cancers 147
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care 144
Integrative pathway enrichment analysis of multivariate omics data 144
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma 144
Preclinical Modelling of PDA: Is Organoid the New Black? 144
Profiling mTOR pathway in neuroendocrine tumors 143
Current role of non-coding RNAs in the clinical setting 143
Mutational profile of GNAQQ209 in human tumors 141
Totale 19.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.601
article - articoli 73.552
book - libri 0
conference - conferenze 2.669
curatela - curatele 0
other - altro 2.586
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.794
Totale 161.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 0 0 0 50 39 37 29 58 35 16 76 200
2022/20231.889 113 222 150 328 160 453 23 115 230 19 41 35
2023/20241.225 43 76 78 106 139 211 61 144 29 85 186 67
2024/20253.647 179 161 177 529 201 179 245 216 524 251 373 612
2025/202610.120 691 491 705 1.582 2.524 618 906 530 828 665 248 332
2026/20272.224 166 364 428 1.266 0 0 0 0 0 0 0 0
Totale 23.420